Mental Health during the COVID-19 Crisis in Africa: A Systematic Review and Meta-Analysis

Abstract

We aim to provide a systematic review and meta-analysis of the prevalence rates of mental health symptoms among major African populations during the COVID-19 pandemic. We include articles from PubMed, Embase, Web of Science, PsycINFO, and medRxiv between 1 February 2020 and 6 February 2021, and pooled data using random-effects meta-analyses. We identify 28 studies and 32 independent samples from 12 African countries with a total of 15,071 participants. The pooled prevalence of anxiety was 37% in 27 studies, of depression was 45% in 24 studies, and of insomnia was 28% in 9 studies. The pooled prevalence rates of anxiety, depression, and insomnia in North Africa (44%, 55%, and 31%, respectively) are higher than those in Sub-Saharan Africa (31%, 30%, and 24%, respectively). We find (a) a scarcity of studies in several African countries with a high number of COVID-19 cases; (b) high heterogeneity among the studies; (c) the extent and pattern of prevalence of mental health symptoms in Africa is high and differs from elsewhere—more African adults suffer from depression rather than anxiety and insomnia during COVID 19 compared to adult populations in other countries/regions. Hence, our findings carry crucial implications and impact future research to enable evidence-based medicine in Africa.

1. Introduction

Africa, a huge continent that is home to 1.37 billion people, is particularly vulnerable to the highly contagious COVID-19 disease due to its unique and severe limitations [1,2]. Africa has limited medical facilities and resources [3], such as the lack of advanced healthcare facilities [4] and intensive care units, understaffed and overcrowded hospitals, crippling healthcare coordination and transportation, limited access to sanitary items and clean water [5], inefficient primary healthcare infrastructure [6], limited vaccinology training programs [7], and limited vaccine penetration in its fight against the COVID-19 pandemic. The COVID-19 pandemic threatens to further constrain the limited medical services and African peoples’ access to mental healthcare. A number of studies have started researching the mental health conditions of Africans under the COVID-19 pandemic. For example, a study in Ethiopia found that people using public transportation had developed and experienced general anxiety disorder [8], and research showed a significant number of healthcare workers in Libya had low levels of knowledge, awareness, and preparedness for COVID-19 [9]. Such emerging evidence suggests the importance of studying mental health symptoms in Africa during the COVID-19 pandemic [10].

However, the emerging evidence on mental health symptoms during the COVID-19 pandemic in Africa has reported a heterogeneous set of findings. For example, one study found that 56.3% of healthcare workers in Libya had depressive symptoms [11]; another study found the prevalence of depression in Ethiopia to be 21.2% [12]. To understand the prevalence of mental health symptoms across the studies, several meta-analyses have been conducted in other regions during the COVID-19 pandemic [13,14,15,16,17,18,19], but not in Africa, one of the least developed and least understood continents.

This study aims to address this gap by providing a systematic review to estimate the pooled prevalence of anxiety, depression, and insomnia in Africa during the COVID-19 pandemic. This systematic review and meta-analysis of studies on Africa helps to guide practitioners and mental health researchers during this continued global pandemic in several ways. First, we benchmark and compare the pooled prevalence of mental health symptoms in Africa vs. those reported by meta-analyses in other regions. Second, we assess the pooled prevalence rates of anxiety, depression, and insomnia in Sub-Saharan Africa vs. North Africa to reveal heterogeneities within Africa. Third, we pool and compare the prevalence among the key populations studied so far, including frontline healthcare workers (HCWs), general HCWs, general population, and medical students. The findings reveal unique patterns in Africa to guide psychiatric organizations such as the World Psychiatric Association (WPA) in their effort to improve/understand/address mental health services in Africa.

2. Methodology and Materials

2.1. Protocol Registration

To gain an understanding of the prevalence of mental health symptoms during COVID-19 in Africa, we conducted a systematic review and meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 2020 and registered in the International Prospective Register of Systematic Reviews (PROSPERO: RD42020224458). Please see Appendix A for the PRISMA Checklist.

2.2. Data Sources and Search Strategy

This paper is part of a large project to examine the prevalence of mental health symptoms during the COVID-19 pandemic in key geographical areas. We performed a comprehensive literature search in the databases of PubMed, Embase, PsycINFO, Web of Science, and medRxiv from 1 February 2020 to 6 February 2021. We used the search query reported in Appendix Table A1 and entered keywords in each database using Boolean operators within the titles, abstracts, keywords, and subject headings (for example, MeSH terms).

2.3. Eligibility Criteria

In this systematic review, we included original empirical studies that examined the impact of the COVID-19 pandemic on adults’ mental health in Africa if they met the following criteria: Outcomes: reported the prevalence of depression, anxiety, or insomnia during COVID-19 pandemic.Measurements/Instruments: using any validated measurement tools or scales. Population: included adult participants including frontline HCWs, general HCWs, general adult population, or adult medical students from any African countries. Methodological design: cross-sectional or cohort.Language: published in English.

We excluded studies based on the following criteria:Population: children, adolescents, or specific niche adult populations, such as patients, adults under quarantine, pregnant/postpartum women.Methodological design: non-primary studies, such as reviews or meta-analyses, qualitative or case studies without a validated instrument, interventional studies, interviews, or news reports.Measurements/Instruments: non-validated instruments measuring mental health outcomes (i.e., self-made questionnaire) or instruments missing a validated cutoff score to calculate the prevalence rate.

A researcher (W.X.) contacted the authors of papers that missed important information. For example: (1) if the surveyed population in the paper included both targeted and excluded populations in a way the prevalence rate of the relevant population cannot be identified; (2) if the prevalence rates were not reported; (3) if overall prevalence rates were reported without specifying cutoff points to determine whether it is mild above or moderate above; or (4) if the paper lacks any important information, such as response rate, time frame of data collection, sample size, or gender proportions.

2.4. Screening and Data Extraction

One researcher (J.C.) exported the included articles from the databases into an EndNote library where we identified duplicates and then imported the articles to Rayyan for screening. Two researchers (B.Z.C. and A.D.) independently screened the imported articles based on their titles and abstracts, and a third researcher (R.K.D.) resolved any conflicts. Six coders, in pairs (W.X. and J.Y., B.Z.C. and A.D., R.Z.C. and S.M.), assessed the eligibility of each paper to be included in the review. They read the full texts to extract the relevant data into a coding book based on a coding protocol; both were developed in a previous study [20]. The coding book records all the coded information, such as authors’ names, year of the publication, title, publication status, sample locations, date of data collection, sample size, response rate, population, age (mean, SD, min, and max), gender proportion, instruments, cutoff scores used, and the prevalence/mean/SD of the mental health outcomes. Each paper was double-coded and crosschecked independently by a pair of coders. The pair discussed any discrepancies. In cases where the pair of coders failed to resolve the discrepancies, a third coder (R.K.D.) checked the paper independently to determine its coding. Another coder (R.Z.C.) double-checked important data including the population, sample size, mental health outcomes, outcome levels, instruments, and prevalence, and further checked papers with unusual prevalence, cutoff scores, and numbers for sensitivity analysis.

2.5. Assessment of Bias Risk

We followed prior meta-analyses [21,22] by using the Mixed Methods Appraisal Tool (MMAT) [23,24,25,26] with seven questions to gauge the quality of the studies included in the meta-analysis. We selected MMAT as it is adjudged to be the most comprehensive and best approach available for evaluating multi-method studies [21,27]. A pair of coders individually evaluated the risk of non-response bias and assessed the quality based on the representativeness of sample, appropriateness of measurements/instruments using the MMAT. Each article was assigned a final quality score ranging from 0 to 7. Articles with a quality score higher than 6 were considered low bias risk, articles with a score between 5 and 6 were classified as medium bias risk, and articles with a score below 5 were classified as high bias risk. Any discrepancies regarding the quality scores were resolved by a discussion between the pair of coders or the lead researcher.

2.6. Statistical Analysis

The overall prevalence and 95% confidence intervals of mental health symptoms were pooled using Stata 16.1. Following prior literature on the prevalence of mental health symptoms, the random-effects model was used to extract the pooled estimates [28]. The random-effects model assumes that the included studies in the meta-analysis are random samples from a large population to generalize findings beyond the chosen studies [29]. We also performed subgroup analyses by the key potential sources of heterogeneity of outcomes (three types of mental health symptoms), the severity of outcome (above mild/above moderate/above severe), four major population groups (frontline HCWs, general HCWs, general population, students), and two regions in Africa (Sub-Saharan vs. Northern Africa).

3. Results

3.1. Study Screening

As illustrated in Figure 1, our search in the selected databases and other sources yielded 6949 papers. Removing the duplicates, we examined the titles and abstracts of the remaining 3346 papers and excluded 2662 of them that did not meet the inclusion criteria in the screening process. By examining the full text of the remaining 684 pa-pers, we identified 150 papers relevant to the meta-analyses. However, 95 papers missed certain information. We sent out two rounds of emails to their authors to re-quest the missing information, and 75 of them responded, adding 8 sets of prevalence data. The final sample contains 168 studies with the information required for the me-ta-analysis. Among these 168 studies, 28 articles involve participants from Africa.

3.2. Study Characteristics

In this meta-analysis, we included 28 [8,11,12,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54] articles that contain 32 samples and 137 individual prevalence rates from a total of 15,071 individual participants. Appendix Table A3 lists the 28 articles included in this meta-analysis. Table 1 summarizes the key characteristics of the included papers.

Among the 32 independent samples, 9.4% studied frontline HCWs, 37.5% studied general HCWs, 46.9% studied the general population, and 6.3% studied medical students. Sample prevalence was 45.3% for anxiety, 39.4% for depression, and 15.3% for insomnia. Respectively, 40.2%, 32.9%, 24.1%, and 2.8% of prevalence reported at the mild above, moderate above, severe above, and overall level by the severity of the symptoms. Cross-sectional surveys comprised 96.7% of the studies while 3.3% used cohort-based studies. All the articles were published in journals. The median number of individuals per sample was 327 (range: 48 to 2430) with a median female proportion of 56.6% (range: 0% to 100%) and a median response rate of 49.0% (range: 18.2% to 94.2%).

3.3. Pooled Prevalence Rates of Mental Health Symptoms

The prevalence rates of the 32 samples were pooled by the subgroups (Table 2).

The overall prevalence of mental health symptoms is 39% in Africa; 31 samples from 27 studies reported the prevalence of anxiety symptoms among 14,847 participants. Several anxiety instruments were used, with the Generalized Anxiety Disorder 7-items scale (GAD-7) used the most (51.8%), followed by the Depression, Anxiety and Stress Scale—21 Items (DASS-21) (22.2%), Hospital Anxiety and Depression Scale (HADS) (14.8%), Hamilton Anxiety Rating (HARS) (3.7%), Hopkins Symptoms Checklist (HSCL) (3.7%), Self-Reporting Questionnaire (SRQ) (3.7%). In the random-effects model, the pooled prevalence of anxiety was 37% (95% CI: 31–44%) in the 23 studies (Figure 2A). This finding suggests that, on average, 37% of the adults in Africa during COVID-19 had anxiety symptoms. The variance of true effects (tau2) across studies is 0.30. The prediction internal is 1% to 91% based on a normal distribution; hence, we expect that the prevalence of anxiety symptoms in any comparable studies will fall in this range.

Samples of our total 24 articles that we reported in this meta-analysis were on depression, for a total of 12,688 respondents. Several depression instruments were used, including Patient Health Questionnaire (PHQ)-9 (45.8%), DASS-21 (25.0%), HADS (16.6%), Beck Depression Inventory (BDI) (4.2%), CES-D (4.2%), and SRQ (4.2%). In the random-effects model, the pooled prevalence of depression was 45% (95% CI: 38–53%) among the 24 studies (Figure 2B). This finding suggests that, on average, 45% of the adults in Africa during COVID-19 had depression symptoms. The variance of true effects (tau2) across studies is 0.31 with a prediction internal from 1% to 99%.

Ten samples of the nine articles that we reported in this meta-analysis studied insomnia, for a total of 4144 respondents. The Insomnia Severity Index (ISI) (88.9%) and Athens Insomnia Scale (AIS) (11.1%) were used to measure insomnia. In the random-effects model, the pooled prevalence of insomnia is 28% (95% CI: 18–39%). This finding suggests that on average 28% of the adults in Africa during COVID-19 had insomnia symptoms. The variance of true effects (tau2) across studies is 0.30 with a prediction internal from 0.1% to 70%.

The overall prevalence rates of mental health symptoms that surpassed the cutoff values of mild, moderate, and severe symptoms were 62%, 34%, and 14%, respectively. The overall prevalence of mental health symptoms in frontline HCWs, general HCWs, general population, and medical students in African countries are 49%, 36%, 38%, and 38%, respectively. The range of I² is 98.4–99.1%, which is similar to those in the published meta-analyses on the same topic [13,14,15,16,17,19]. By geographical regions, the prevalence of mental health symptoms is higher in North Africa (46%) than in Sub-Saharan Africa (30%). By time frame, the prevalence of mental health symptoms is higher in the first six months of the COVID-10 pandemic (November 2019 to April 2020, 42%) than in the subsequent period (26%).

3.4. Study Quality

Overall, 6 studies (21.4%) are of higher quality, 22 studies (78.8%) have a medium quality, and none of the studies have low quality. Subgroup analysis suggests the studies with high quality (51%) reported a significantly higher prevalence of mental health symptoms in Africa than studies with medium quality (37%) (Table 2).

3.5. Sensitivity Analysis

Conventional funnel plots have been found to be inaccurate for proportion study meta-analyses [55]. Due to higher sensitivity and power, a better approach for publication bias graphical representation is a DOI plot in combination with the Luis Furuya–Kanamori (LFK) index rather than using a funnel plot and Egger’s regression [44,45]. Asymmetry is assessed quantitatively through the LFK index. Scores are ±1, between ±1 and ±2, or ±2, indicating no asymmetry, minor asymmetry, and major asymmetry, respectively. No asymmetry is depicted in Figure 3, indicating a DOI plot and LFK index of 0.13. Therefore, the presence of publication bias is unlikely. Further sensitivity analysis was conducted on publication status and sample size; no significant influence was found.

4. Discussion

4.1. Comparisons of Results with Prior Meta-Analyses

Our meta-analytical findings revealed several crucial pieces of evidence on the prevalence of mental health symptoms during the COVID-19 crisis in Africa. Given this study is the first such meta-analysis, it would be useful to compare our findings from Africa with some published meta-analyses in other regions. The meta-analytical evidence shows more African adults suffered from depression (45%) and anxiety (37%) than insomnia (28%)—a pattern different from those in other countries. For example, more Chinese adults suffered from insomnia (19%) than anxiety (11%) and depression (13%) [20], and more Spanish adults suffered from insomnia (52%) than anxiety (20%) and depression (23%) [56].

The extant meta-analyses on COVID-19 mental health covered very limited regions, mostly in China and several other developed countries. Moreover, the extant meta-analytical evidence covered the literature published before May 2020, which was at the early onset of the COVID-19 pandemic. We include articles published by February 2021 to cover more recent findings and enable better accumulative evidence on the prevalence of mental health symptoms in Africa.

Our finding on the pooled prevalence rates of anxiety in Africa mostly exceeded the reported prevalence rates by meta-analyses in other geographical areas. The pooled prevalence rate for anxiety in the African population is 37%, which is significantly higher than those in China reported in Bareeqa et al. (2020) (22%; p-value < 0.0001), Pappa et al. (2020) (23%; p-value < 0.0001), Krishnamoorthy et al., 2020 (26%; p-value < 0.0001), and Ren et al., 2020 (25%; p-value < 0.0001) [13,14,15,16], and those in Spain (20%; p-value < 0.0001) [56]. However, notably, the pooled prevalence rate for anxiety in South Asian countries is significantly higher than that in Africa (41.3%; p-value < 0.0001) [57]. In addition, the pooled prevalence of anxiety in Africa (37%) is higher than those in individual cross-country individual studies, such as a study of 10 countries (China, India, Japan, Iran, Iraq, Italy, Nepal, Nigeria, Spain, and the UK) (32%; p-value < 0.0001) [19] and a study in 17 countries in the regions of Asia (China, India, Japan, Pakistan, Singapore, Vietnam), Middle East (Iran, Israel), Europe (Denmark, Greece, Italy, Spain, Turkey), and Latin America (Argentina, Brazil, Chile, and Mexico) (33%; p-value < 0.0001) [58]. Moreover, we find that the pooled prevalence rate of anxiety among frontline HCWs in Africa (51%) is significantly higher than Bareeqa et al. (2020) (24%; p-value < 0.0001), Krishnamoorthy et al., 2020 (26%; p-value < 0.0001), and Ren et al., 2020 (27%; p-value < 0.0001) [13,15,16]. Similarly, we find that the pooled prevalence rate of anxiety among the general population (37%) in Africa is significantly higher than Ren et al., 2020 (24%; p-value < 0.0001) [15].

Our finding on the pooled prevalence rates of depression in Africa exceeded the reported prevalence rates by meta-analyses in most of the other geographical areas. The pooled prevalence rate for depression in the African population (45%) is significantly higher than those in China reported by Bareeqa et al. (2020) (27%; p-value < 0.0001), Pappa et al. (2020) (23%; p-value < 0.0001), Krishnamoorthy et al., 2020 (26%; p-value < 0.0001), and Ren et al., 2020 (28%; p-value < 0.0001) [13,14,15,16]. The pooled prevalence rate for depression in the African population (45%) is higher than those in Spain (23%; p-value < 0.0001) [56] and in South Asian countries reported by Hossain et al. (2020) (34%; p-value < 0.0001) [57]. The pooled prevalence for depression in Africa (45%) is also higher than the pooled prevalence in a study including over 17 countries reported by Luo et al. (28%; p-value < 0.0001) [58] and another study of 10 countries reported by Salari et al. (34%; p-value < 0.0001) [19]. However, the prevalence rate for depression in Africa is lower than Italy—the country with the highest prevalence for depression (67%) [58]. Furthermore, we find that the pooled prevalence rate of depression among frontline HCWs (55%) is significantly higher than Bareeqa et al. (2020) (32%; p-value < 0.0001), Krishnamoorthy et al., 2020 (25%; p-value < 0.0001), and Ren et al., 2020 (25%; p-value < 0.0001). Moreover, the pooled prevalence rate of depression among the general population (42%) in Africa is significantly higher than Krishnamoorthy et al., 2020 (24%; p-value < 0.0001).

The pooled prevalence rate for insomnia in the African population (28%) is similar to those in China [20], but significantly lower than those in Spain (52%; p-value < 0.0001) [56], Germany (39%; p-value < 0.0001), Italy (55%; p-value < 0.0001), and France (51%; p-value < 0.0001), as well as the pooled prevalence in the 13 countries, including Australia, Bahrain, Canada, Germany, Greece, Iraq, India, Mexico, and the USA (36%; p-value < 0.0001), as reported by Jahrami et al. (2021) [59].

The comparisons above show that the pooled prevalence rates for the African population are significantly higher than in the populations in most other regions, suggesting that the mental health symptoms under COVID-19 may not be uniform across regions or countries, and it is worthwhile for individual studies to explore the mental health conditions around the globe and for meta-analytical studies to pool the prevalence across regions.

The subgroup analysis results that the pooled prevalence rates of anxiety, depression, and insomnia in Sub-Saharan Africa (31%, 30%, and 24%, respectively) are significantly lower than those reported in North Africa (44%, 55%, and 31%, respectively) suggest a high heterogeneous prevalence of mental health symptoms within the mega-regions of Africa (see Appendix Table A2). The prevalence rate differences between Sub-Saharan Africa and North Africa may arise due to lack of awareness of the danger of COVID-19 due to insufficient COVID-19 testing or the lower death rates due to the younger population in Sub-Saharan Africa [60]. Our results suggest future research can further examine why such heterogeneity in the prevalence rates for the mental health symptoms occur between Sub-Saharan Africa and North Africa.

4.2. Comparisons of COVID vs. Pre-COVID Findings in Africa

To assess the prevalence of mental health symptoms during COVID-19, we benchmark the meta-analytical findings with the pre-COVID estimates of mental health symptoms in several African countries. For example, in Egypt, the prevalence of depressive symptoms among university students in 2004 was 71% (95% CI  =  67.1–72.8) with 28.2% (95% CI  =  25.4–36.9) suffering from moderate depression and 8.8% suffering from severe depression (95% CI  =  7.1–10.7) [61], and the overall prevalence of mental health disorders in a representative sample of adults from five regions in Egypt in 2003 was 16.93% [62]. The prevalence of mental distress among working adults in Addis Ababa, Ethiopia between December 2009 and January 2010 was 17.7% [63], while the prevalence of common mental disorder symptoms among adults in rural Ethiopia was 27.9% (95% CI  =  25.6–30.2), with mild, moderate, and severe thresholds at 13.8%, 9.0%, and 5.1%, respectively [64]. The prevalence of common mental disorders among adults in Kombolcha town in Ethiopia from March to April 2013 was 32.4% (95% CI = 30.3–34.5) [65]. In a representative sample of the Moroccan general population, 26.5% suffered from depressive disorder and 37% suffered from at least one anxiety disorder [66], while the prevalence rate of anxiety disorder was 25.5% [67]. In Nigeria, the prevalence of depression in a community sample from Oyo state was found to be 5.2% [68], while the prevalence rates of depressive and anxiety disorders from Ebonyi state were 70% and 85.3%, respectively [69]. Among Nigerian medical students from the University of Ibadan, the prevalence of anxiety and depression was 26.5% and 10.1%, respectively [70]; from Enugu State University of Science and Technology, the prevalence of anxiety disorders was 14.3% [71]. In a nationally representative sample of South African adults between 2002 and 2004, 4.9% suffered from major depressive disorder and 8.1% suffered from any anxiety disorder [72]. A recent population-based study on adults from six of eleven South African provinces documented that 47.3% and 17.7% of the surveyed adults suffered from minimal or mild depression and moderate to severe depression, respectively [73]. In adults from Rwanda over a three-month period in 2008, the overall prevalence of depression and PTSD was 22.7% and 26.1%, respectively [74]. From a nationally representative sample in Ghana in 2009–2010, the prevalence of psychological distress was 18.7% with 11.7% and 7.0% suffering from moderate and severe psychological distress, respectively [75]. In urban Ghana in 2010, the prevalence of depressive disorder and mental distress was 12.7% and 29.88%, respectively [76]. These higher pre-COVID baseline estimates of prevalence of mental health symptoms across African countries corroborate our meta-analytical results, which, in a consistent manner, find the prevalence to be on the high side among various African populations. We encourage future research to continue monitoring mental health symptoms in the African population to gather more evidence as COVID-19 continues.

4.3. Practical Implications of Our Findings for Psychiatrists/Healthcare Organizations

Our meta-analysis put forward evidence of a high proportion of mental health symptoms among the general population and healthcare workers (HCWs) during COVID-19 in Africa. The fear, worry, and uncertainty surrounding such an unknown threat and containment strategies can put a burden on mental health. The higher prevalence rates of depression in the African population compared to those reported elsewhere could be due to the higher baseline prevalence rates in Africa. A meta-analysis of studies published between 1 January 2006 and 31 July 2011, showed that the pooled prevalence rate of depression symptoms and major depression in Sub-Saharan Africa was 31% and 18%, respectively [77]. Between 2000 and 2015, while Africa’s population grew by 49%, some mental health and substance use disorders increased by 52% [78]. Making issues worse, mental health symptoms received less attention in underdeveloped economies [79]; for instance, less than 10% of people suffering from depression in low-resource settings have access to mental health treatment [80] despite depression being one of the major causes of disability. The vast majority of Africa suffers from lack of affordable oxygen supply in hospitals [81], high prevalence of multimorbidity [82], low-income, high mortality rates, malnutrition, high incidence of infectious diseases, poor health facilities [83,84], specifically mental health resources, programs, or facilities, [79], which all can present unique situations under the COVID-19 pandemic, in terms of the mental health of the African population.

Our finding that frontline HCWs suffered a much higher prevalence of mental health symptoms (49%) than other populations (general HCWs (36%), general population (38%), medical students (38%)) suggests that healthcare organizations need to pay special attention to providing frontline HCWs with proper mental and healthcare support during the COVID-19 crisis. Our finding of higher prevalence rates of depression (45%) than anxiety (37%) and insomnia (28%) in Africa—a pattern different from elsewhere—suggests not only the extent, but also the patterns of mental health issues could be unique in Africa, or at least vary across geographical regions. As such, psychiatric organizations, such as the World Psychiatric Association (WPA), need to consider the mental health in African countries differently to customize mental health services.

4.4. Limitations and Future Work

Our meta-analysis is not free of limitations. First, the validity of our findings depends on the quality and reporting of the original studies included in the meta-analysis. The individual mental health studies employed a variety of instruments, cutoff scores, levels of cutoff scores to classify the severity of mental illness, and various reporting standards. For example, many studies report the overall prevalence rates without specifying which/how cutoff scores are utilized. While we tried to reduce the additional noise and variance in the meta-analysis by paying extra attention to the severity, cutoff points, and the manners in which individual articles utilized and reported cutoff points, the profusion of different practices can lead to some biases and noise. Second, this systematic review identified empirical studies from only 12 out of the 48 Africa countries. No studies have appeared on the mental health of people in three quarters of African countries, even though those African countries are not immune to the COVID-19 pandemic. Hence, we call for research to investigate the mental health in Africa, the least studied continent with most of the countries not studied at all. A possible reason is that we included articles published in English, which may result in some biases. Third, 96.7% of the studies included in this meta-analysis conducted cross-sectional surveys, whereas only 3.3% of the articles used cohort studies. We believe scholars need to focus more on cohort-based studies to examine mental health symptoms during COVID-19 over time to further our understanding regarding how a highly contagious disease can affect psychological well-being. Finally, we only focus on studies that collected data in African countries, and we call for future meta-analyses in other countries or regions, as the COVID-19 pandemic is unfolding around the globe.

5. Conclusions

This paper presents, to the best of our knowledge, the first systematic review and meta-analysis of the prevalence of mental health symptoms during the COVID-19 crisis in Africa. The findings provide evidence that the prevalence of anxiety and depression is much higher in the African population compared to those reported elsewhere. Given our findings and the unique challenges Africa faces under COVID-19, we call for more studies on mental health in Africa.

Disclosure Statement

All authors have completed the Unified Competing Interest form and declare: no support from any organization for the submitted work that may create conflict of interest; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.

Competing interests

Conflicts of InterestThe authors declare no conflict of interest.

References

1. Lone S.A., Ahmad A.. COVID-19 pandemic—An African perspective. Emerg. Microbes Infect.. 2020 doi:10.1080/22221751.2020.1775132 PubMed
2. Moore M., Gelfeld B., Adeyemi Okunogbe C.P.. Identifying future disease hot spots: Infectious disease vulnerability index. Rand Health Q.. 2017 doi:10.7249/rhq-06-03-05 PubMed
3. El-Sadr W.M., Justman J.. Africa in the Path of Covid-19. N. Engl. J. Med.. 2020 doi:10.1056/NEJMp2008193 PubMed
4. Dare L., Buch E.. The future of health care in Africa. BMJ. 2005 doi:10.1136/bmj.331.7507.1 PubMed
5. World Report on Ageing and Health. 2015
6. Moosa S., Peersman W., Derese A., Kidd M., Pettigrew L.M., Howe A. et al. Emerging role of family medicine in South Africa. BMJ Glob. Health. 2018 doi:10.1136/bmjgh-2018-000736 PubMed
7. Moïsi J., Madhi S.A., Rees H.. Vaccinology in sub-Saharan Africa. BMJ Glob. Health. 2019 doi:10.1136/bmjgh-2018-001363 PubMed
8. Kassaw C., Pandey D.. COVID-19 Pandemic Related to Anxiety Disorder Among Communities Using Public Transport at Addis Ababa, Ethiopia, March 2020: Cross-sectional Study Design. Hum. Arenas. 2021 doi:10.1007/s42087-020-00166-y
9. Elhadi M., Msherghi A., Alkeelani M., Zorgani A., Zaid A., Alsuyihili A. et al. Assessment of Healthcare Workers’ Levels of Preparedness and Awareness Regarding COVID-19 Infection in Low-Resource Settings. Am. J. Trop. Med. Hyg.. 2020 doi:10.4269/ajtmh.20-0330 PubMed
10. Agberotimi S.F., Akinsola O.S., Oguntayo R., Olaseni A.O.. Interactions between socioeconomic status and mental health out-comes in the nigerian context amid covid-19 pandemic: A comparative study. Front. Psychol.. 2020 doi:10.3389/fpsyg.2020.559819 PubMed
11. Elhadi M., Msherghi A., Elgzairi M., Alhashimi A., Bouhuwaish A., Biala M. et al. Psychological status of healthcare workers during the civil war and COVID-19 pandemic: A cross-sectional study. J. Psychosom. Res.. 2020 doi:10.1016/j.jpsychores.2020.110221 PubMed
12. Aylie N.S., Mekonen M.A., Mekuria R.M.. The Psychological Impacts of COVID-19 Pandemic Among University Students in Bench-Sheko Zone, South-west Ethiopia: A Community-based Cross-sectional Study. Psychol. Res. Behav. Manag.. 2020 doi:10.2147/PRBM.S275593 PubMed
13. Bareeqa S.B., Ahmed S.I., Samar S.S., Yasin W., Zehra S., Monese G.M. et al. Prevalence of depression, anxiety and stress in china during COVID-19 pandemic: A systematic review with meta-analysis. Int. J. Psychiatry Med.. 2021 doi:10.1177/0091217420978005 PubMed
14. Pappa S., Ntella V., Giannakas T., Giannakoulis V.G., Papoutsi E., Katsaounou P.. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain. Behav. Immun.. 2020 doi:10.1016/j.bbi.2020.05.026 PubMed
15. Ren X., Huang W., Pan H., Huang T., Wang X., Ma Y.. Mental Health During the Covid-19 Outbreak in China: A Meta-Analysis. Psychiatr. Q.. 2020 doi:10.1007/s11126-020-09796-5 PubMed
16. Krishnamoorthy Y., Nagarajan R., Saya G.K., Menon V.. Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res.. 2020 doi:10.1016/j.psychres.2020.113382 PubMed
17. Salari N., Khazaie H., Hosseinian-Far A., Ghasemi H., Mohammadi M., Shohaimi S. et al. The prevalence of sleep disturb-ances among physicians and nurses facing the COVID-19 patients: A systematic review and meta-analysis. Glob. Health. 2020 doi:10.1186/s12992-020-00620-0 PubMed
18. Kisely S., Warren N., McMahon L., Dalais C., Henry I., Siskind D.. Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: Rapid review and meta-analysis. BMJ. 2020 doi:10.1136/bmj.m1642 PubMed
19. Salari N., Hosseinian-Far A., Jalali R., Vaisi-Raygani A., Rasoulpoor S., Mohammadi M. et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and meta-analysis. Glob. Health. 2020 doi:10.1186/s12992-020-00589-w PubMed
20. Chen X., Chen J., Zhang M., Chen R.Z., Dong R.K., Dong Z. et al. One Year of Evidence on Mental Health in the COVID-19 Cri-sis-A Systematic Review and Meta-Analysis. medRxiv. 2021
21. de Pablo G.S., Vaquerizo-Serrano J., Catalan A., Arango C., Moreno C., Ferre F. et al. Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis. J. Affect. Disord.. 2020 doi:10.1016/j.jad.2020.06.022 PubMed
22. Usher K., Jackson D., Durkin J., Gyamfi N., Bhullar N.. Pandemic-related behaviours and psychological outcomes; A rapid literature review to explain COVID-19 behaviours. Int. J. Ment. Health Nurs.. 2020 doi:10.1111/inm.12790 PubMed
23. Hong Q.N., Fàbregues S., Bartlett G., Boardman F., Cargo M., Dagenais P. et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ. Inf.. 2018 doi:10.3233/EFI-180221
24. Hong Q.N., Gonzalez-Reyes A., Pluye P.. Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT). J. Eval. Clin. Pr.. 2018 doi:10.1111/jep.12884 PubMed
25. Boderie N.W., Mölenberg F.J., Sheikh A., Bramer W.M., Burdorf A., van Lenthe F.J. et al. Assessing public support for extending smoke-free policies beyond enclosed public places and workplaces: Protocol for a systematic review and meta-analysis. BMJ Open. 2021 doi:10.1136/bmjopen-2020-040167 PubMed
26. Mekonnen A.B., Redley B., de Courten B., Manias E.. Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis. Br. J. Clin. Pharmacol.. 2021 doi:10.1111/bcp.14870 PubMed
27. Behghadami M.A., Janati A., Sadeghibazargani H., Gholizadeh M., Rahmani F., Arab-Zozani M. et al. Assessing Preparedness of Non-Hospital Health Centers to Provide Primary Emergency Care; A Systematic Review. Bull. Emerg. Trauma. 2019 doi:10.29252/beat-070301 PubMed
28. DerSimonian R., Laird N.. Meta-analysis in clinical trials. Control Clin. Trials. 1986 doi:10.1016/0197-2456(86)90046-2 PubMed
29. Cheung M.W.-L., Ho R.C.M., Lim Y., Mak A.. Conducting a meta-analysis: Basics and good practices. Int. J. Rheum. Dis.. 2012 doi:10.1111/j.1756-185X.2012.01712.x PubMed
30. Kim A.W., Nyengerai T., Mendenhall E.. Evaluating the mental health impacts of the COVID-19 pandemic: Perceived risk of COVID-19 infection and childhood trauma predict adult depressive symptoms in urban South Africa. Psychol. Med.. 2020 doi:10.1017/S0033291720003414 PubMed
31. Naidoo T., Tomita A., Paruk S.. Burnout, anxiety and depression risk in medical doctors working in KwaZulu-Natal Province, South Africa: Evidence from a multi-site study of resource-constrained government hospitals in a generalised HIV epidemic setting. PLoS ONE. 2020 doi:10.1371/journal.pone.0239753 PubMed
32. Souilhi A., Gabsi A., Letaief-Ksontini F., Chraiet N., Yahiaoui Y., Mghirbi F. et al. 1572P Psychological impact of the COVID-19 pandemic on health care workers in oncology in Tunisia. Ann. Oncol.. 2020 doi:10.1016/j.annonc.2020.08.2055
33. Elhadi M., Buzreg A., Bouhuwaish A., Khaled A., Alhadi A., Msherghi A. et al. Psychological Impact of the Civil War and COVID-19 on Libyan Medical Students: A Cross-Sectional Study. Front. Psychol.. 2020 doi:10.3389/fpsyg.2020.570435 PubMed
34. Sediri S., Zgueb Y., Ouanes S., Ouali U., Bourgou S., Jomli R. et al. Women’s mental health: Acute impact of COVID-19 pan-demic on domestic violence. Arch. Womens Ment. Health. 2020 doi:10.1007/s00737-020-01082-4 PubMed
35. Rakhmanov O., Demir A., Dane S.. A brief communication: Anxiety and depression levels in the staff of a Nigerian private university during COVID 19 pandemic outbreak. J. Res. Med. Dent. Sci.. 2020
36. Elkholy H., Tawfik F., Ibrahim I., Salah El-din W., Sabry M., Mohammed S. et al. Mental health of frontline healthcare work-ers exposed to COVID-19 in Egypt: A call for action. Int. J. Soc. Psychiatry. 2020 doi:10.1177/0020764020960192 PubMed
37. Keubo F.R.N., Mboua P.C., Tadongfack T.D., Tchoffo E.F., Tatang C.T., Zeuna J.I. et al. Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales Médico-Psychologiques, Revue Psychiatrique. 2021 doi:10.1016/j.amp.2020.08.012 PubMed
38. Sagaon-Teyssier L., Kamissoko A., Yattassaye A., Diallo F., Castro D.R., Delabre R. et al. Assessment of mental health out-comes and associated factors among workers in community-based HIV care centers in the early stage of the COVID-19 outbreak in Mali. Health Policy Open. 2020 doi:10.1016/j.hpopen.2020.100017 PubMed
39. Youssef N., Mostafa A., Ezzat R., Yosef M., El Kassas M.. Mental health status of health-care professionals working in quaran-tine and non-quarantine Egyptian hospitals during the COVID-19 pandemic. East Mediterr Health J.. 2020 doi:10.26719/emhj.20.116 PubMed
40. Kassaw C.. The Magnitude of Psychological Problem and Associated Factor in Response to COVID-19 Pandemic Among Communities Living in Addis Ababa, Ethiopia, March 2020: A Cross-Sectional Study Design. Psychol. Res. Behav. Manag.. 2020 doi:10.2147/PRBM.S256551 PubMed
41. Idrissi A.J., Lamkaddem A., Benouajjit A., Ben El Bouaazzaoui M., El Houari F., Alami M. et al. Sleep quality and mental health in the context of COVID-19 pandemic and lockdown in Morocco. Sleep Med.. 2020 doi:10.1016/j.sleep.2020.07.045 PubMed
42. Shuwiekh H.A., Kira I.A., Sous M.S.F., Ashby J.S., Alhuwailah A., Baali S.B.A. et al. The differential mental health impact of COVID-19 in Arab countries. Curr. Psychol.. 2020 doi:10.1007/s12144-020-01148-7 PubMed
43. Cénat J.M., Dalexis R.D., Guerrier M., Noorishad P.G., Derivois D., Bukaka J. et al. Frequency and correlates of anxiety symp-toms during the COVID-19 pandemic in low-and middle-income countries: A multinational study. J. Psychiatr. Res.. 2021 doi:10.1016/j.jpsychires.2020.09.031 PubMed
44. Teshome A., Glagn M., Shegaze M., Tekabe B., Getie A., Assefa G. et al. Generalized Anxiety Disorder and Its Associated Fac-tors Among Health Care Workers Fighting COVID-19 in Southern Ethiopia. Psychol. Res. Behav. Manag.. 2020 doi:10.2147/PRBM.S282822 PubMed
45. Mboua P.C., Keubo F.R.N., Fouaka S.G.N.. Anxiety and Depression Associated with the Management of COVID-19 among Healthcare Personnel in Cameroon. Evol. Psychiatr.. 2020 doi:10.1016/j.evopsy.2020.11.002 PubMed
46. Yitayih Y., Mekonen S., Zeynudin A., Mengistie E., Ambelu A.. Mental health of healthcare professionals during the early stage of the COVID-19 pandemic in Ethiopia. BJPsych. Open. 2021 doi:10.1192/bjo.2020.130 PubMed
47. Kounou K.B., Guédénon K.M., Foli A.A.D., Gnassounou-Akpa E.. Mental health of medical professionals during the COVID-19 pandemic in Togo. Psychiatry Clin. Neurosci.. 2020 doi:10.1111/pcn.13108 PubMed
48. Essangri H., Sabir M., Benkabbou A., Majbar M.A., Amrani L., Ghannam A. et al. Predictive Factors for Impaired Mental Health among Medical Students during the Early Stage of the COVID-19 Pandemic in Morocco. Am. J. Trop. Med. Hyg.. 2021 doi:10.4269/ajtmh.20-1302 PubMed
49. Kibret S., Teshome D., Fenta E., Hunie M., Tamire T.. Prevalence of anxiety towards COVID-19 and its associated factors among healthcare workers in a Hospital of Ethiopia. PLoS ONE. 2020 doi:10.1371/journal.pone.0243022 PubMed
50. Omar S.S., Dawood W., Eid N., Eldeeb D., Munir A., Arafat W.. Psychological and Sexual Health During the COVID-19 Pandemic in Egypt: Are Women Suffering More?. Sex. Med.. 2021 doi:10.1016/j.esxm.2020.100295 PubMed
51. Arafa A., Mohamed A., Saleh L., Senosy S.. Psychological Impacts of the COVID-19 Pandemic on the Public in Egypt. Community Ment. Health J.. 2021 doi:10.1007/s10597-020-00701-9 PubMed
52. Mulatu H.A., Tesfaye M., Woldeyes E., Bayisa T., Fisseha H., Asrat R.. The prevalence of common mental disorders among health care professionals during the COVID-19 pandemic at a tertiary Hospital in East Africa. medRxiv. 2020 doi:10.1101/2020.10.29.20222430 PubMed
53. Mekonen E., Shetie B., Muluneh N.. The Psychological Impact of COVID-19 Outbreak on Nurses Working in the Northwest of Amhara Regional State Referral Hospitals, Northwest Ethiopia. Psychol. Res. Behav. Manag.. 2021 doi:10.2147/PRBM.S291446 PubMed
54. Elhadi M., Msherghi A., Elgzairi M., Alhashimi A., Bouhuwaish A., Biala M. et al. The mental well-being of frontline physicians working in civil wars under coronavirus disease 2019 pandemic conditions. Front. Psychiatry. 2020 doi:10.3389/fpsyt.2020.598720 PubMed
55. Hunter J.P., Saratzis A., Sutton A.J., Boucher R.H., Sayers R.D., Bown M.. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J. Clin. Epidemiol.. 2014 doi:10.1016/j.jclinepi.2014.03.003 PubMed
56. Chen R.Z., Zhang S.X., Xu W., Yin A., Dong R.K., Chen B.Z.. Meta-Analysis on Mental health disorders in Spain in the COVID-19 Crisis. medRxiv. 2021
57. Hossain M., Rahman M., Trisha N.F., Tasnim S., Nuzhath T., Hasan N.T. et al. Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis. Heliyon. 2021 doi:10.1016/j.heliyon.2021.e06677 PubMed
58. Luo M., Guo L., Yu M., Jiang W., Wang H.. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public—A systematic review and meta-analysis. Psychiatry Res.. 2020 doi:10.1016/j.psychres.2020.113190 PubMed
59. Jahrami H., Bahammam A.S., Bragazzi N.L., Saif Z., Faris M., Vitiello M.V.. Sleep problems during the COVID-19 pandemic by population: A systematic review and meta-analysis. J. Clin. Sleep Med.. 2021 doi:10.5664/jcsm.8930 PubMed
60. Kabiru C.W., O Izugbara C., Beguy N.. The health and wellbeing of young people in sub-Saharan Africa: An under-researched area?. BMC Int. Health Hum. Rights. 2013 doi:10.1186/1472-698X-13-11 PubMed
61. Ibrahim A.K., Kelly S.J., Glazebrook C.. Analysis of an Egyptian study on the socioeconomic distribution of depressive symp-toms among undergraduates. Soc. Psychiatry Psychiatr. Epidemiol.. 2012 doi:10.1007/s00127-011-0400-x PubMed
62. Ghanem M., Gadallah M., Meky F., Mourad S., El Kholy G.. National Survey of Prevalence of Mental Disorders in Egypt: Preliminary survey. East. Mediterr. Health J.. 2009 doi:10.26719/2009.15.1.65 PubMed
63. Gelaye B., Lemma S., Deyassa N., Bahretibeb Y., Tesfaye M., Berhane Y. et al. Prevalence and Correlates of Mental Distress Among Working Adults in Ethiopia. Clin. Pr. Epidemiol. Ment. Health. 2012 doi:10.2174/1745017901208010126 PubMed
64. Fekadu A., Medhin G., Selamu M., Hailemariam M., Alem A., Giorgis T.W. et al. Population level mental distress in rural Ethiopia. BMC Psychiatry. 2014 doi:10.1186/1471-244X-14-194 PubMed
65. Yimam K., Kebede Y., Azale T.. Prevalence of common mental disorders and associated factors among adults in Kombolcha Town, Northeast Ethiopia. J. Depress. Anxiety. 2014 doi:10.4172/2167-1044.S1-007
66. Kadri N., Agoub M., Assouab F., Tazi M.A., Didouh A., Stewart R. et al. Moroccan national study on prevalence of mental dis-orders: A community-based epidemiological study. Acta Psychiatr. Scand.. 2010 doi:10.1111/j.1600-0447.2009.01431.x PubMed
67. Kadri N., Agoub M., El Gnaoui S., Berrada S., Moussaoui D.. Prevalence of anxiety disorders: A population-based epidemio-logical study in metropolitan area of Casablanca, Morocco. Ann. Gen. Psychiatry.. 2007 doi:10.1186/1744-859X-6-6 PubMed
68. Amoran O., Lawoyin T., Lasebikan V.. Prevalence of depression among adults in Oyo State, Nigeria: A comparative study of rural and urban communities. Aust. J. Rural. Health. 2007 doi:10.1111/j.1440-1584.2006.00794.x PubMed
69. Stanley N., Chinwe E.S.. Prevalence of Mental Disorders in Abakaliki, Ebonyi State, Southeastern Nigeria. J. Am. Psychiatr. Nurses Assoc.. 2020 doi:10.1177/1078390320951910 PubMed
70. Nwachukwu C.E., Olufunmilayo E.O., Otor V.O., Yakubu A.O., Akingbade A.E., Odefemi O.F. et al. Common mental health problems and associated factors among medical students of University of Ibadan, Nigeria. J. Ment. Health. 2021 doi:10.1080/09638237.2021.1875404 PubMed
71. Chinawa A.T., Chinawa J.M., Aniwada E., Amadi O., Ndukuba A.C., Uwaezuoke S.N.. Spectrum of Anxiety Disorders Among Medical Students in a Nigerian Medical School: A Cross-Sectional Study With Standardized Screening Tools. J. Educ. Dev. Psychol.. 2018 doi:10.5539/jedp.v8n2p132
72. Williams D.R., Herman A., Stein D., Heeringa S.G., Jackson P.B., Moomal H. et al. Twelve-month mental disorders in South Africa: Prevalence, service use and demographic correlates in the population-based South African Stress and Health Study. Psychol. Med.. 2007 doi:10.1017/S0033291707001420 PubMed
73. Peltzer K., Pengpid S.. Social determinants of depression among adults in South Africa. J. Hum. Behav. Soc. Environ.. 2020 doi:10.1080/10911359.2019.1703236
74. Munyandamutsa N., Nkubamugisha P.M., Gex-Fabry M., Eytan A.. Mental and physical health in Rwanda 14 years after the genocide. Soc. Psychiatry Psychiatr. Epidemiol.. 2012 doi:10.1007/s00127-012-0494-9 PubMed
75. Sipsma H., Ofori-Atta A., Canavan M., Osei-Akoto I., Udry C., Bradley E.H.. Poor mental health in Ghana: Who is at risk?. BMC Public Health. 2013 doi:10.1186/1471-2458-13-288 PubMed
76. Dzator J.. Hard Times and Common Mental Health Disorders in Developing Countries: Insights from Urban Ghana. J. Behav. Health Serv. Res.. 2012 doi:10.1007/s11414-012-9305-z PubMed
77. Nakimuli-Mpungu E., Bass J.K., Alexandre P., Mills E.J., Musisi S., Ram M. et al. Depression, alcohol use and adherence to an-tiretroviral therapy in sub-Saharan Africa: A systematic review. AIDS Behav.. 2012 doi:10.1007/s10461-011-0087-8 PubMed
78. Sankoh O., Sevalie S., Weston M.. Mental health in Africa. Lancet Glob. Health. 2018 doi:10.1016/S2214-109X(18)30303-6 PubMed
79. Okasha A.. Mental health in Africa: The role of the WPA. World Psychiatry. 2002 PubMed
80. Sweetland A.C., Belkin G.S., Verdeli H.. Measuring depression and anxiety in Sub-Saharan Africa. Depress. Anxiety. 2014 doi:10.1002/da.22142 PubMed
81. Stein F., Perry M., Banda G., Woolhouse M., Mutapi F.. Oxygen provision to fight COVID-19 in sub-Saharan Africa. BMJ Glob. Health. 2020 doi:10.1136/bmjgh-2020-002786 PubMed
82. Chang A.Y., Gómez-Olivé F.X., Payne C., Rohr J.K., Manne-Goehler J., Wade A.N. et al. Chronic multimorbidity among older adults in rural South Africa. BMJ Glob. Health. 2019 doi:10.1136/bmjgh-2018-001386 PubMed
83. Human Development Report: 1995. 1995
84. Brown J.C.. African Development Indicators 1998/99. 1998